nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—Acute leukaemia—Carmustine—malignant glioma	0.0144	0.0255	CcSEcCtD
Saquinavir—Acute leukaemia—Temozolomide—malignant glioma	0.0139	0.0246	CcSEcCtD
Saquinavir—Clotting—Temozolomide—malignant glioma	0.0111	0.0197	CcSEcCtD
Saquinavir—Paresis—Temozolomide—malignant glioma	0.0109	0.0193	CcSEcCtD
Saquinavir—Opportunistic infection—Temozolomide—malignant glioma	0.00988	0.0175	CcSEcCtD
Saquinavir—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0097	0.0172	CcSEcCtD
Saquinavir—Faecal incontinence—Carmustine—malignant glioma	0.00816	0.0144	CcSEcCtD
Saquinavir—Faecal incontinence—Temozolomide—malignant glioma	0.00788	0.0139	CcSEcCtD
Saquinavir—Cerebral haemorrhage—Carmustine—malignant glioma	0.00744	0.0132	CcSEcCtD
Saquinavir—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00719	0.0127	CcSEcCtD
Saquinavir—Lopinavir—CYP2B6—malignant glioma	0.00682	0.37	CrCbGaD
Saquinavir—Transaminases increased—Carmustine—malignant glioma	0.00677	0.012	CcSEcCtD
Saquinavir—Haemorrhoids—Temozolomide—malignant glioma	0.00677	0.012	CcSEcCtD
Saquinavir—Nelfinavir—CYP2B6—malignant glioma	0.00634	0.344	CrCbGaD
Saquinavir—Cyst—Carmustine—malignant glioma	0.00616	0.0109	CcSEcCtD
Saquinavir—Tooth disorder—Temozolomide—malignant glioma	0.00613	0.0109	CcSEcCtD
Saquinavir—Myopathy—Temozolomide—malignant glioma	0.00567	0.01	CcSEcCtD
Saquinavir—Lung disorder—Temozolomide—malignant glioma	0.00562	0.00994	CcSEcCtD
Saquinavir—Herpes zoster—Temozolomide—malignant glioma	0.00528	0.00935	CcSEcCtD
Saquinavir—Mitiglinide—PPARG—malignant glioma	0.00527	0.286	CrCbGaD
Saquinavir—Abscess—Carmustine—malignant glioma	0.0052	0.0092	CcSEcCtD
Saquinavir—Coagulopathy—Temozolomide—malignant glioma	0.00511	0.00904	CcSEcCtD
Saquinavir—Hyperaesthesia—Temozolomide—malignant glioma	0.00507	0.00897	CcSEcCtD
Saquinavir—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00484	0.00855	CcSEcCtD
Saquinavir—Endocrine disorder—Temozolomide—malignant glioma	0.0048	0.00849	CcSEcCtD
Saquinavir—Speech disorder—Carmustine—malignant glioma	0.00479	0.00847	CcSEcCtD
Saquinavir—Speech disorder—Temozolomide—malignant glioma	0.00463	0.00818	CcSEcCtD
Saquinavir—Drug interaction—Carmustine—malignant glioma	0.00444	0.00785	CcSEcCtD
Saquinavir—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00437	0.00774	CcSEcCtD
Saquinavir—Herpes simplex—Temozolomide—malignant glioma	0.00432	0.00764	CcSEcCtD
Saquinavir—Coordination abnormal—Carmustine—malignant glioma	0.00419	0.00742	CcSEcCtD
Saquinavir—Hearing impaired—Temozolomide—malignant glioma	0.00418	0.00739	CcSEcCtD
Saquinavir—Coordination abnormal—Temozolomide—malignant glioma	0.00405	0.00717	CcSEcCtD
Saquinavir—Musculoskeletal pain—Temozolomide—malignant glioma	0.00403	0.00712	CcSEcCtD
Saquinavir—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00398	0.00704	CcSEcCtD
Saquinavir—Candida infection—Carmustine—malignant glioma	0.00393	0.00695	CcSEcCtD
Saquinavir—Neuropathy—Carmustine—malignant glioma	0.00387	0.00684	CcSEcCtD
Saquinavir—Candida infection—Temozolomide—malignant glioma	0.0038	0.00672	CcSEcCtD
Saquinavir—Neuropathy—Temozolomide—malignant glioma	0.00374	0.00661	CcSEcCtD
Saquinavir—Neoplasm—Carmustine—malignant glioma	0.00372	0.00658	CcSEcCtD
Saquinavir—Dry eye—Temozolomide—malignant glioma	0.00367	0.0065	CcSEcCtD
Saquinavir—Neoplasm—Temozolomide—malignant glioma	0.0036	0.00636	CcSEcCtD
Saquinavir—Thrombophlebitis—Carmustine—malignant glioma	0.00345	0.00611	CcSEcCtD
Saquinavir—Diabetes mellitus—Carmustine—malignant glioma	0.00344	0.00608	CcSEcCtD
Saquinavir—Ear pain—Temozolomide—malignant glioma	0.00338	0.00599	CcSEcCtD
Saquinavir—Thrombophlebitis—Temozolomide—malignant glioma	0.00334	0.0059	CcSEcCtD
Saquinavir—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00332	0.00587	CcSEcCtD
Saquinavir—Injury—Carmustine—malignant glioma	0.00325	0.00575	CcSEcCtD
Saquinavir—Deafness—Temozolomide—malignant glioma	0.00323	0.00571	CcSEcCtD
Saquinavir—Amnesia—Carmustine—malignant glioma	0.00318	0.00563	CcSEcCtD
Saquinavir—Hot flush—Temozolomide—malignant glioma	0.00309	0.00546	CcSEcCtD
Saquinavir—Amnesia—Temozolomide—malignant glioma	0.00307	0.00544	CcSEcCtD
Saquinavir—Menopausal symptoms—Temozolomide—malignant glioma	0.00306	0.00541	CcSEcCtD
Saquinavir—Thirst—Temozolomide—malignant glioma	0.00303	0.00537	CcSEcCtD
Saquinavir—Hyponatraemia—Carmustine—malignant glioma	0.003	0.00531	CcSEcCtD
Saquinavir—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00299	0.00529	CcSEcCtD
Saquinavir—Ataxia—Carmustine—malignant glioma	0.00281	0.00497	CcSEcCtD
Saquinavir—ORM1—vertebral column—malignant glioma	0.00281	0.21	CbGeAlD
Saquinavir—Liver function test abnormal—Carmustine—malignant glioma	0.00276	0.00488	CcSEcCtD
Saquinavir—Hypokalaemia—Carmustine—malignant glioma	0.00272	0.00481	CcSEcCtD
Saquinavir—Ataxia—Temozolomide—malignant glioma	0.00272	0.0048	CcSEcCtD
Saquinavir—Dehydration—Temozolomide—malignant glioma	0.00269	0.00475	CcSEcCtD
Saquinavir—Dry skin—Temozolomide—malignant glioma	0.00265	0.00468	CcSEcCtD
Saquinavir—Muscular weakness—Carmustine—malignant glioma	0.00264	0.00466	CcSEcCtD
Saquinavir—Hypokalaemia—Temozolomide—malignant glioma	0.00263	0.00465	CcSEcCtD
Saquinavir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0026	0.0046	CcSEcCtD
Saquinavir—Dysphagia—Carmustine—malignant glioma	0.00258	0.00457	CcSEcCtD
Saquinavir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00255	0.00451	CcSEcCtD
Saquinavir—Muscular weakness—Temozolomide—malignant glioma	0.00255	0.00451	CcSEcCtD
Saquinavir—Abdominal distension—Temozolomide—malignant glioma	0.00251	0.00444	CcSEcCtD
Saquinavir—Dysphagia—Temozolomide—malignant glioma	0.0025	0.00442	CcSEcCtD
Saquinavir—Pancytopenia—Carmustine—malignant glioma	0.00245	0.00434	CcSEcCtD
Saquinavir—Sweating increased—Temozolomide—malignant glioma	0.00243	0.0043	CcSEcCtD
Saquinavir—Neutropenia—Carmustine—malignant glioma	0.00242	0.00427	CcSEcCtD
Saquinavir—Bronchitis—Temozolomide—malignant glioma	0.0024	0.00425	CcSEcCtD
Saquinavir—Pancytopenia—Temozolomide—malignant glioma	0.00237	0.00419	CcSEcCtD
Saquinavir—Neutropenia—Temozolomide—malignant glioma	0.00233	0.00413	CcSEcCtD
Saquinavir—Hyperglycaemia—Carmustine—malignant glioma	0.00233	0.00412	CcSEcCtD
Saquinavir—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00232	0.0041	CcSEcCtD
Saquinavir—Pneumonia—Carmustine—malignant glioma	0.00232	0.0041	CcSEcCtD
Saquinavir—Erectile dysfunction—Temozolomide—malignant glioma	0.0023	0.00407	CcSEcCtD
Saquinavir—Depression—Carmustine—malignant glioma	0.0023	0.00406	CcSEcCtD
Saquinavir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00228	0.00403	CcSEcCtD
Saquinavir—Weight increased—Temozolomide—malignant glioma	0.00227	0.00402	CcSEcCtD
Saquinavir—Renal failure—Carmustine—malignant glioma	0.00226	0.004	CcSEcCtD
Saquinavir—Weight decreased—Temozolomide—malignant glioma	0.00226	0.00399	CcSEcCtD
Saquinavir—Neuropathy peripheral—Carmustine—malignant glioma	0.00226	0.00399	CcSEcCtD
Saquinavir—Hyperglycaemia—Temozolomide—malignant glioma	0.00225	0.00398	CcSEcCtD
Saquinavir—Stomatitis—Carmustine—malignant glioma	0.00224	0.00397	CcSEcCtD
Saquinavir—Urinary tract infection—Carmustine—malignant glioma	0.00224	0.00396	CcSEcCtD
Saquinavir—Pneumonia—Temozolomide—malignant glioma	0.00224	0.00396	CcSEcCtD
Saquinavir—Infestation—Temozolomide—malignant glioma	0.00223	0.00394	CcSEcCtD
Saquinavir—Infestation NOS—Temozolomide—malignant glioma	0.00223	0.00394	CcSEcCtD
Saquinavir—Depression—Temozolomide—malignant glioma	0.00222	0.00393	CcSEcCtD
Saquinavir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00221	0.0039	CcSEcCtD
Saquinavir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00218	0.00386	CcSEcCtD
Saquinavir—Stomatitis—Temozolomide—malignant glioma	0.00217	0.00384	CcSEcCtD
Saquinavir—Urinary tract infection—Temozolomide—malignant glioma	0.00216	0.00383	CcSEcCtD
Saquinavir—Hepatobiliary disease—Temozolomide—malignant glioma	0.0021	0.00372	CcSEcCtD
Saquinavir—Sinusitis—Temozolomide—malignant glioma	0.00209	0.00369	CcSEcCtD
Saquinavir—Haemoglobin—Carmustine—malignant glioma	0.00208	0.00368	CcSEcCtD
Saquinavir—Haemorrhage—Carmustine—malignant glioma	0.00207	0.00366	CcSEcCtD
Saquinavir—Hypoaesthesia—Carmustine—malignant glioma	0.00206	0.00364	CcSEcCtD
Saquinavir—Hallucination—Carmustine—malignant glioma	0.00206	0.00364	CcSEcCtD
Saquinavir—Connective tissue disorder—Carmustine—malignant glioma	0.00203	0.00359	CcSEcCtD
Saquinavir—Haemoglobin—Temozolomide—malignant glioma	0.00201	0.00355	CcSEcCtD
Saquinavir—Hepatitis—Temozolomide—malignant glioma	0.002	0.00353	CcSEcCtD
Saquinavir—Haemorrhage—Temozolomide—malignant glioma	0.002	0.00353	CcSEcCtD
Saquinavir—Visual impairment—Carmustine—malignant glioma	0.00199	0.00352	CcSEcCtD
Saquinavir—Hypoaesthesia—Temozolomide—malignant glioma	0.00199	0.00352	CcSEcCtD
Saquinavir—Hallucination—Temozolomide—malignant glioma	0.00199	0.00352	CcSEcCtD
Saquinavir—Pharyngitis—Temozolomide—malignant glioma	0.00198	0.00351	CcSEcCtD
Saquinavir—Urinary tract disorder—Temozolomide—malignant glioma	0.00197	0.00349	CcSEcCtD
Saquinavir—Connective tissue disorder—Temozolomide—malignant glioma	0.00196	0.00347	CcSEcCtD
Saquinavir—Urethral disorder—Temozolomide—malignant glioma	0.00196	0.00346	CcSEcCtD
Saquinavir—Eye disorder—Carmustine—malignant glioma	0.00193	0.00342	CcSEcCtD
Saquinavir—Visual impairment—Temozolomide—malignant glioma	0.00193	0.00341	CcSEcCtD
Saquinavir—Erythema multiforme—Temozolomide—malignant glioma	0.00189	0.00334	CcSEcCtD
Saquinavir—Eye disorder—Temozolomide—malignant glioma	0.00187	0.0033	CcSEcCtD
Saquinavir—Tinnitus—Temozolomide—malignant glioma	0.00186	0.00329	CcSEcCtD
Saquinavir—Cardiac disorder—Temozolomide—malignant glioma	0.00185	0.00328	CcSEcCtD
Saquinavir—Alopecia—Carmustine—malignant glioma	0.00183	0.00323	CcSEcCtD
Saquinavir—Angiopathy—Temozolomide—malignant glioma	0.00181	0.00321	CcSEcCtD
Saquinavir—Mental disorder—Carmustine—malignant glioma	0.00181	0.0032	CcSEcCtD
Saquinavir—Immune system disorder—Temozolomide—malignant glioma	0.0018	0.00319	CcSEcCtD
Saquinavir—Mediastinal disorder—Temozolomide—malignant glioma	0.0018	0.00318	CcSEcCtD
Saquinavir—Malnutrition—Carmustine—malignant glioma	0.0018	0.00318	CcSEcCtD
Saquinavir—Erythema—Carmustine—malignant glioma	0.0018	0.00318	CcSEcCtD
Saquinavir—Chills—Temozolomide—malignant glioma	0.00179	0.00317	CcSEcCtD
Saquinavir—Alopecia—Temozolomide—malignant glioma	0.00177	0.00312	CcSEcCtD
Saquinavir—Mental disorder—Temozolomide—malignant glioma	0.00175	0.0031	CcSEcCtD
Saquinavir—Back pain—Carmustine—malignant glioma	0.00174	0.00308	CcSEcCtD
Saquinavir—Erythema—Temozolomide—malignant glioma	0.00174	0.00308	CcSEcCtD
Saquinavir—Malnutrition—Temozolomide—malignant glioma	0.00174	0.00308	CcSEcCtD
Saquinavir—Dysgeusia—Temozolomide—malignant glioma	0.0017	0.00301	CcSEcCtD
Saquinavir—Tremor—Carmustine—malignant glioma	0.00169	0.00298	CcSEcCtD
Saquinavir—Back pain—Temozolomide—malignant glioma	0.00168	0.00298	CcSEcCtD
Saquinavir—Anaemia—Carmustine—malignant glioma	0.00166	0.00294	CcSEcCtD
Saquinavir—Agitation—Carmustine—malignant glioma	0.00165	0.00293	CcSEcCtD
Saquinavir—Tremor—Temozolomide—malignant glioma	0.00163	0.00288	CcSEcCtD
Saquinavir—Ill-defined disorder—Temozolomide—malignant glioma	0.00161	0.00285	CcSEcCtD
Saquinavir—Leukopenia—Carmustine—malignant glioma	0.00161	0.00285	CcSEcCtD
Saquinavir—Anaemia—Temozolomide—malignant glioma	0.00161	0.00284	CcSEcCtD
Saquinavir—Agitation—Temozolomide—malignant glioma	0.0016	0.00283	CcSEcCtD
Saquinavir—Malaise—Temozolomide—malignant glioma	0.00157	0.00277	CcSEcCtD
Saquinavir—Vertigo—Temozolomide—malignant glioma	0.00156	0.00276	CcSEcCtD
Saquinavir—Convulsion—Carmustine—malignant glioma	0.00156	0.00276	CcSEcCtD
Saquinavir—Leukopenia—Temozolomide—malignant glioma	0.00156	0.00275	CcSEcCtD
Saquinavir—Hypertension—Carmustine—malignant glioma	0.00155	0.00275	CcSEcCtD
Saquinavir—Myalgia—Carmustine—malignant glioma	0.00153	0.00271	CcSEcCtD
Saquinavir—Chest pain—Carmustine—malignant glioma	0.00153	0.00271	CcSEcCtD
Saquinavir—Anxiety—Carmustine—malignant glioma	0.00153	0.0027	CcSEcCtD
Saquinavir—Cough—Temozolomide—malignant glioma	0.00152	0.00268	CcSEcCtD
Saquinavir—Convulsion—Temozolomide—malignant glioma	0.00151	0.00267	CcSEcCtD
Saquinavir—Hypertension—Temozolomide—malignant glioma	0.0015	0.00266	CcSEcCtD
Saquinavir—Confusional state—Carmustine—malignant glioma	0.00148	0.00262	CcSEcCtD
Saquinavir—Myalgia—Temozolomide—malignant glioma	0.00148	0.00262	CcSEcCtD
Saquinavir—Arthralgia—Temozolomide—malignant glioma	0.00148	0.00262	CcSEcCtD
Saquinavir—Anxiety—Temozolomide—malignant glioma	0.00148	0.00261	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00147	0.0026	CcSEcCtD
Saquinavir—Oedema—Carmustine—malignant glioma	0.00147	0.0026	CcSEcCtD
Saquinavir—Discomfort—Temozolomide—malignant glioma	0.00146	0.00259	CcSEcCtD
Saquinavir—Infection—Carmustine—malignant glioma	0.00146	0.00258	CcSEcCtD
Saquinavir—Dry mouth—Temozolomide—malignant glioma	0.00145	0.00256	CcSEcCtD
Saquinavir—Thrombocytopenia—Carmustine—malignant glioma	0.00144	0.00254	CcSEcCtD
Saquinavir—Confusional state—Temozolomide—malignant glioma	0.00143	0.00253	CcSEcCtD
Saquinavir—Oedema—Temozolomide—malignant glioma	0.00142	0.00251	CcSEcCtD
Saquinavir—Infection—Temozolomide—malignant glioma	0.00141	0.00249	CcSEcCtD
Saquinavir—Anorexia—Carmustine—malignant glioma	0.0014	0.00248	CcSEcCtD
Saquinavir—Nervous system disorder—Temozolomide—malignant glioma	0.00139	0.00246	CcSEcCtD
Saquinavir—Thrombocytopenia—Temozolomide—malignant glioma	0.00139	0.00246	CcSEcCtD
Saquinavir—Skin disorder—Temozolomide—malignant glioma	0.00138	0.00244	CcSEcCtD
Saquinavir—Hypotension—Carmustine—malignant glioma	0.00137	0.00243	CcSEcCtD
Saquinavir—Hyperhidrosis—Temozolomide—malignant glioma	0.00137	0.00243	CcSEcCtD
Saquinavir—Anorexia—Temozolomide—malignant glioma	0.00135	0.00239	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00134	0.00237	CcSEcCtD
Saquinavir—Insomnia—Carmustine—malignant glioma	0.00133	0.00235	CcSEcCtD
Saquinavir—Paraesthesia—Carmustine—malignant glioma	0.00132	0.00233	CcSEcCtD
Saquinavir—Dyspnoea—Carmustine—malignant glioma	0.00131	0.00232	CcSEcCtD
Saquinavir—Somnolence—Carmustine—malignant glioma	0.00131	0.00231	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00129	0.00229	CcSEcCtD
Saquinavir—Insomnia—Temozolomide—malignant glioma	0.00128	0.00227	CcSEcCtD
Saquinavir—Decreased appetite—Carmustine—malignant glioma	0.00128	0.00226	CcSEcCtD
Saquinavir—Paraesthesia—Temozolomide—malignant glioma	0.00127	0.00225	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00127	0.00224	CcSEcCtD
Saquinavir—Dyspnoea—Temozolomide—malignant glioma	0.00127	0.00224	CcSEcCtD
Saquinavir—Somnolence—Temozolomide—malignant glioma	0.00126	0.00223	CcSEcCtD
Saquinavir—Pain—Carmustine—malignant glioma	0.00126	0.00222	CcSEcCtD
Saquinavir—Constipation—Carmustine—malignant glioma	0.00126	0.00222	CcSEcCtD
Saquinavir—Dyspepsia—Temozolomide—malignant glioma	0.00125	0.00221	CcSEcCtD
Saquinavir—Decreased appetite—Temozolomide—malignant glioma	0.00123	0.00218	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00123	0.00217	CcSEcCtD
Saquinavir—Fatigue—Temozolomide—malignant glioma	0.00122	0.00216	CcSEcCtD
Saquinavir—Constipation—Temozolomide—malignant glioma	0.00121	0.00215	CcSEcCtD
Saquinavir—Pain—Temozolomide—malignant glioma	0.00121	0.00215	CcSEcCtD
Saquinavir—Feeling abnormal—Carmustine—malignant glioma	0.00121	0.00214	CcSEcCtD
Saquinavir—Gastrointestinal pain—Carmustine—malignant glioma	0.0012	0.00212	CcSEcCtD
Saquinavir—Feeling abnormal—Temozolomide—malignant glioma	0.00117	0.00207	CcSEcCtD
Saquinavir—Abdominal pain—Carmustine—malignant glioma	0.00116	0.00205	CcSEcCtD
Saquinavir—Body temperature increased—Carmustine—malignant glioma	0.00116	0.00205	CcSEcCtD
Saquinavir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00116	0.00205	CcSEcCtD
Saquinavir—Urticaria—Temozolomide—malignant glioma	0.00113	0.00199	CcSEcCtD
Saquinavir—Body temperature increased—Temozolomide—malignant glioma	0.00112	0.00198	CcSEcCtD
Saquinavir—Abdominal pain—Temozolomide—malignant glioma	0.00112	0.00198	CcSEcCtD
Saquinavir—Hypersensitivity—Carmustine—malignant glioma	0.00108	0.00191	CcSEcCtD
Saquinavir—Asthenia—Carmustine—malignant glioma	0.00105	0.00186	CcSEcCtD
Saquinavir—Hypersensitivity—Temozolomide—malignant glioma	0.00105	0.00185	CcSEcCtD
Saquinavir—Asthenia—Temozolomide—malignant glioma	0.00102	0.0018	CcSEcCtD
Saquinavir—Diarrhoea—Carmustine—malignant glioma	0.001	0.00178	CcSEcCtD
Saquinavir—Pruritus—Temozolomide—malignant glioma	0.001	0.00178	CcSEcCtD
Saquinavir—Dizziness—Carmustine—malignant glioma	0.000971	0.00172	CcSEcCtD
Saquinavir—Diarrhoea—Temozolomide—malignant glioma	0.000971	0.00172	CcSEcCtD
Saquinavir—Dizziness—Temozolomide—malignant glioma	0.000939	0.00166	CcSEcCtD
Saquinavir—Vomiting—Carmustine—malignant glioma	0.000934	0.00165	CcSEcCtD
Saquinavir—Rash—Carmustine—malignant glioma	0.000926	0.00164	CcSEcCtD
Saquinavir—Dermatitis—Carmustine—malignant glioma	0.000925	0.00164	CcSEcCtD
Saquinavir—Headache—Carmustine—malignant glioma	0.00092	0.00163	CcSEcCtD
Saquinavir—Vomiting—Temozolomide—malignant glioma	0.000902	0.0016	CcSEcCtD
Saquinavir—Rash—Temozolomide—malignant glioma	0.000895	0.00158	CcSEcCtD
Saquinavir—Dermatitis—Temozolomide—malignant glioma	0.000894	0.00158	CcSEcCtD
Saquinavir—Headache—Temozolomide—malignant glioma	0.000889	0.00157	CcSEcCtD
Saquinavir—Nausea—Carmustine—malignant glioma	0.000872	0.00154	CcSEcCtD
Saquinavir—Nausea—Temozolomide—malignant glioma	0.000843	0.00149	CcSEcCtD
Saquinavir—CYP11A1—medulla oblongata—malignant glioma	0.000582	0.0436	CbGeAlD
Saquinavir—SLC22A1—telencephalon—malignant glioma	0.000512	0.0384	CbGeAlD
Saquinavir—SLCO1A2—telencephalon—malignant glioma	0.000493	0.037	CbGeAlD
Saquinavir—CYP11A1—central nervous system—malignant glioma	0.000421	0.0315	CbGeAlD
Saquinavir—ABCC1—telencephalon—malignant glioma	0.000405	0.0303	CbGeAlD
Saquinavir—ORM1—spinal cord—malignant glioma	0.000392	0.0294	CbGeAlD
Saquinavir—SLCO1A2—medulla oblongata—malignant glioma	0.000388	0.029	CbGeAlD
Saquinavir—SLCO1A2—midbrain—malignant glioma	0.000354	0.0265	CbGeAlD
Saquinavir—SLCO1A2—spinal cord—malignant glioma	0.000346	0.0259	CbGeAlD
Saquinavir—ABCB1—blood vessel—malignant glioma	0.000341	0.0255	CbGeAlD
Saquinavir—ABCG2—telencephalon—malignant glioma	0.000335	0.0251	CbGeAlD
Saquinavir—CYP11A1—brain—malignant glioma	0.000334	0.025	CbGeAlD
Saquinavir—ORM1—central nervous system—malignant glioma	0.000318	0.0238	CbGeAlD
Saquinavir—SLC22A1—central nervous system—malignant glioma	0.000291	0.0218	CbGeAlD
Saquinavir—SLCO1A2—central nervous system—malignant glioma	0.00028	0.021	CbGeAlD
Saquinavir—SLCO1A2—cerebellum—malignant glioma	0.000274	0.0205	CbGeAlD
Saquinavir—ABCG2—medulla oblongata—malignant glioma	0.000263	0.0197	CbGeAlD
Saquinavir—CYP2D6—brainstem—malignant glioma	0.000259	0.0194	CbGeAlD
Saquinavir—ABCG2—midbrain—malignant glioma	0.000241	0.018	CbGeAlD
Saquinavir—ABCG2—spinal cord—malignant glioma	0.000235	0.0176	CbGeAlD
Saquinavir—SLC22A1—brain—malignant glioma	0.000231	0.0173	CbGeAlD
Saquinavir—CYP2D6—telencephalon—malignant glioma	0.00023	0.0172	CbGeAlD
Saquinavir—ABCC1—cerebellum—malignant glioma	0.000225	0.0168	CbGeAlD
Saquinavir—SLCO1A2—brain—malignant glioma	0.000223	0.0167	CbGeAlD
Saquinavir—ALB—brain—malignant glioma	0.000221	0.0166	CbGeAlD
Saquinavir—ABCB1—embryo—malignant glioma	0.000203	0.0152	CbGeAlD
Saquinavir—ABCG2—cerebellum—malignant glioma	0.000186	0.0139	CbGeAlD
Saquinavir—ABCC1—brain—malignant glioma	0.000183	0.0137	CbGeAlD
Saquinavir—ABCB1—retina—malignant glioma	0.00018	0.0135	CbGeAlD
Saquinavir—ABCB1—telencephalon—malignant glioma	0.000165	0.0124	CbGeAlD
Saquinavir—CYP2C8—brain—malignant glioma	0.000156	0.0116	CbGeAlD
Saquinavir—ABCG2—brain—malignant glioma	0.000151	0.0113	CbGeAlD
Saquinavir—CYP3A4—central nervous system—malignant glioma	0.000133	0.00994	CbGeAlD
Saquinavir—CYP2D6—central nervous system—malignant glioma	0.000131	0.00978	CbGeAlD
Saquinavir—ABCB1—medulla oblongata—malignant glioma	0.00013	0.00973	CbGeAlD
Saquinavir—CYP2D6—cerebellum—malignant glioma	0.000128	0.00956	CbGeAlD
Saquinavir—ABCB1—midbrain—malignant glioma	0.000119	0.00889	CbGeAlD
Saquinavir—ABCB1—spinal cord—malignant glioma	0.000116	0.00867	CbGeAlD
Saquinavir—CYP2D6—brain—malignant glioma	0.000104	0.00776	CbGeAlD
Saquinavir—ABCB1—central nervous system—malignant glioma	9.39e-05	0.00704	CbGeAlD
Saquinavir—ABCB1—cerebellum—malignant glioma	9.18e-05	0.00688	CbGeAlD
Saquinavir—ABCB1—brain—malignant glioma	7.46e-05	0.00559	CbGeAlD
Saquinavir—CYP3A4—Metabolism—BCAN—malignant glioma	4.98e-05	0.000124	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.98e-05	0.000123	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.96e-05	0.000123	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PIK3CB—malignant glioma	4.96e-05	0.000123	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—BCHE—malignant glioma	4.96e-05	0.000123	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CAT—malignant glioma	4.94e-05	0.000123	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.93e-05	0.000122	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTT1—malignant glioma	4.93e-05	0.000122	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTGS2—malignant glioma	4.91e-05	0.000122	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTT1—malignant glioma	4.9e-05	0.000122	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.9e-05	0.000122	CbGpPWpGaD
Saquinavir—ABCC1—Disease—BRAF—malignant glioma	4.79e-05	0.000119	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PIK3CG—malignant glioma	4.74e-05	0.000118	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CAV1—malignant glioma	4.69e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.68e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.67e-05	0.000116	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—NCOR1—malignant glioma	4.67e-05	0.000116	CbGpPWpGaD
Saquinavir—ABCC1—Disease—AKT2—malignant glioma	4.66e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS1—malignant glioma	4.62e-05	0.000115	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.6e-05	0.000114	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS1—malignant glioma	4.59e-05	0.000114	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PPARG—malignant glioma	4.58e-05	0.000114	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.58e-05	0.000114	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.51e-05	0.000112	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—RAF1—malignant glioma	4.49e-05	0.000111	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PIK3CD—malignant glioma	4.48e-05	0.000111	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.48e-05	0.000111	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CAV1—malignant glioma	4.45e-05	0.000111	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTT1—malignant glioma	4.4e-05	0.000109	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PIK3CB—malignant glioma	4.38e-05	0.000109	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTT1—malignant glioma	4.29e-05	0.000107	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—BCHE—malignant glioma	4.29e-05	0.000107	CbGpPWpGaD
Saquinavir—ABCC1—Disease—FGF2—malignant glioma	4.29e-05	0.000106	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTEN—malignant glioma	4.29e-05	0.000106	CbGpPWpGaD
Saquinavir—ALB—Metabolism—BCHE—malignant glioma	4.27e-05	0.000106	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PIK3CG—malignant glioma	4.27e-05	0.000106	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.26e-05	0.000106	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.25e-05	0.000106	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.24e-05	0.000105	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.23e-05	0.000105	CbGpPWpGaD
Saquinavir—ALB—Metabolism—SLC5A5—malignant glioma	4.22e-05	0.000105	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PIK3CD—malignant glioma	4.17e-05	0.000104	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.17e-05	0.000103	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CAV1—malignant glioma	4.12e-05	0.000102	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS1—malignant glioma	4.12e-05	0.000102	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PPARG—malignant glioma	4.12e-05	0.000102	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.11e-05	0.000102	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.11e-05	0.000102	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CAV1—malignant glioma	4.09e-05	0.000101	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PIK3CG—malignant glioma	4.06e-05	0.000101	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTT1—malignant glioma	4.05e-05	0.0001	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS1—malignant glioma	4.02e-05	9.99e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IL2—malignant glioma	4.02e-05	9.98e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MDM2—malignant glioma	4.01e-05	9.96e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—IDH2—malignant glioma	4.01e-05	9.96e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTT1—malignant glioma	4.01e-05	9.96e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.01e-05	9.95e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—RAF1—malignant glioma	4e-05	9.93e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.99e-05	9.9e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.97e-05	9.86e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ERBB2—malignant glioma	3.96e-05	9.82e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.95e-05	9.81e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSTP1—malignant glioma	3.94e-05	9.79e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PPARG—malignant glioma	3.92e-05	9.72e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PIK3CB—malignant glioma	3.91e-05	9.69e-05	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	3.88e-05	9.64e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTGS2—malignant glioma	3.87e-05	9.61e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CAT—malignant glioma	3.84e-05	9.53e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—BCHE—malignant glioma	3.83e-05	9.51e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CAV1—malignant glioma	3.8e-05	9.44e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS1—malignant glioma	3.79e-05	9.41e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.79e-05	9.4e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.77e-05	9.36e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS1—malignant glioma	3.76e-05	9.33e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PIK3CG—malignant glioma	3.76e-05	9.32e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PIK3CD—malignant glioma	3.75e-05	9.31e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.74e-05	9.3e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—BCHE—malignant glioma	3.74e-05	9.28e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PIK3CG—malignant glioma	3.72e-05	9.24e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—SLC5A5—malignant glioma	3.69e-05	9.17e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PIK3CB—malignant glioma	3.64e-05	9.02e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PPARG—malignant glioma	3.63e-05	9e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NCOR1—malignant glioma	3.62e-05	9e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTGS2—malignant glioma	3.6e-05	8.94e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PPARG—malignant glioma	3.59e-05	8.92e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.58e-05	8.89e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PIK3CD—malignant glioma	3.57e-05	8.85e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.55e-05	8.8e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—BCHE—malignant glioma	3.52e-05	8.75e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—BCHE—malignant glioma	3.49e-05	8.67e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.48e-05	8.64e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.47e-05	8.6e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PIK3CG—malignant glioma	3.46e-05	8.6e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.45e-05	8.57e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—IDH1—malignant glioma	3.45e-05	8.56e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.45e-05	8.55e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—VEGFA—malignant glioma	3.42e-05	8.49e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTP1—malignant glioma	3.42e-05	8.48e-05	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.4e-05	8.45e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTP1—malignant glioma	3.4e-05	8.43e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTEN—malignant glioma	3.38e-05	8.38e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PPARG—malignant glioma	3.34e-05	8.3e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SPHK1—malignant glioma	3.34e-05	8.29e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CAT—malignant glioma	3.32e-05	8.25e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CAT—malignant glioma	3.31e-05	8.2e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PIK3CD—malignant glioma	3.3e-05	8.2e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PIK3CD—malignant glioma	3.27e-05	8.12e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.27e-05	8.12e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PIK3CB—malignant glioma	3.27e-05	8.12e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.26e-05	8.1e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTGS2—malignant glioma	3.24e-05	8.04e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.23e-05	8.03e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTEN—malignant glioma	3.14e-05	7.8e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NCOR1—malignant glioma	3.14e-05	7.79e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NCOR1—malignant glioma	3.12e-05	7.75e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PIK3CB—malignant glioma	3.11e-05	7.72e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.09e-05	7.68e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTGS2—malignant glioma	3.08e-05	7.64e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTP1—malignant glioma	3.05e-05	7.57e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PIK3CD—malignant glioma	3.05e-05	7.56e-05	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PIK3CA—malignant glioma	3.02e-05	7.5e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—STAT3—malignant glioma	3.02e-05	7.49e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTP1—malignant glioma	2.98e-05	7.39e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CAT—malignant glioma	2.97e-05	7.36e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CAV1—malignant glioma	2.95e-05	7.33e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—KRAS—malignant glioma	2.91e-05	7.21e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CAT—malignant glioma	2.9e-05	7.19e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PIK3CB—malignant glioma	2.88e-05	7.14e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.85e-05	7.08e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTGS2—malignant glioma	2.85e-05	7.08e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTGS2—malignant glioma	2.83e-05	7.02e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTEN—malignant glioma	2.83e-05	7.02e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.82e-05	7e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MYC—malignant glioma	2.8e-05	6.96e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTP1—malignant glioma	2.8e-05	6.96e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NCOR1—malignant glioma	2.8e-05	6.95e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTP1—malignant glioma	2.78e-05	6.9e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—EGFR—malignant glioma	2.74e-05	6.81e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NCOR1—malignant glioma	2.74e-05	6.79e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CAT—malignant glioma	2.73e-05	6.77e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CAT—malignant glioma	2.71e-05	6.72e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.69e-05	6.68e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTEN—malignant glioma	2.69e-05	6.67e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PIK3CA—malignant glioma	2.67e-05	6.63e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.65e-05	6.59e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTT1—malignant glioma	2.65e-05	6.57e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTGS2—malignant glioma	2.63e-05	6.53e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PPARG—malignant glioma	2.6e-05	6.45e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—KRAS—malignant glioma	2.59e-05	6.43e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—malignant glioma	2.58e-05	6.41e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NCOR1—malignant glioma	2.58e-05	6.4e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CAV1—malignant glioma	2.56e-05	6.35e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NCOR1—malignant glioma	2.56e-05	6.34e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CAV1—malignant glioma	2.54e-05	6.32e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTEN—malignant glioma	2.49e-05	6.17e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS1—malignant glioma	2.48e-05	6.15e-05	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—AKT1—malignant glioma	2.47e-05	6.13e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTEN—malignant glioma	2.47e-05	6.12e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.44e-05	6.07e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.43e-05	6.03e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PIK3CA—malignant glioma	2.38e-05	5.91e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.37e-05	5.87e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.33e-05	5.79e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PIK3CG—malignant glioma	2.32e-05	5.75e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—BCHE—malignant glioma	2.3e-05	5.72e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTEN—malignant glioma	2.29e-05	5.69e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CAV1—malignant glioma	2.28e-05	5.67e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.28e-05	5.65e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PPARG—malignant glioma	2.25e-05	5.58e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PPARG—malignant glioma	2.24e-05	5.55e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CAV1—malignant glioma	2.23e-05	5.53e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PIK3CA—malignant glioma	2.22e-05	5.5e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.18e-05	5.42e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—AKT1—malignant glioma	2.18e-05	5.41e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CAV1—malignant glioma	2.1e-05	5.21e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CAV1—malignant glioma	2.08e-05	5.17e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.08e-05	5.16e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.06e-05	5.12e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.05e-05	5.09e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTGS2—malignant glioma	2.04e-05	5.07e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PIK3CD—malignant glioma	2.04e-05	5.06e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PIK3CG—malignant glioma	2.03e-05	5.04e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PPARG—malignant glioma	2.01e-05	4.98e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PIK3CA—malignant glioma	1.99e-05	4.95e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.99e-05	4.94e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PPARG—malignant glioma	1.96e-05	4.86e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—AKT1—malignant glioma	1.95e-05	4.83e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.91e-05	4.75e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.9e-05	4.71e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.89e-05	4.7e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PPARG—malignant glioma	1.85e-05	4.58e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTP1—malignant glioma	1.83e-05	4.55e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PPARG—malignant glioma	1.83e-05	4.54e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.83e-05	4.54e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—AKT1—malignant glioma	1.81e-05	4.49e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.79e-05	4.43e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PIK3CD—malignant glioma	1.79e-05	4.43e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CAT—malignant glioma	1.78e-05	4.43e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTEN—malignant glioma	1.78e-05	4.42e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PIK3CB—malignant glioma	1.78e-05	4.41e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS2—malignant glioma	1.77e-05	4.39e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS2—malignant glioma	1.76e-05	4.37e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PIK3CA—malignant glioma	1.75e-05	4.35e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.74e-05	4.32e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NCOR1—malignant glioma	1.69e-05	4.18e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.68e-05	4.18e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.67e-05	4.14e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—AKT1—malignant glioma	1.63e-05	4.04e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.62e-05	4.02e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.59e-05	3.96e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS2—malignant glioma	1.58e-05	3.92e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PIK3CB—malignant glioma	1.56e-05	3.86e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—AKT1—malignant glioma	1.55e-05	3.84e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTEN—malignant glioma	1.54e-05	3.83e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS2—malignant glioma	1.54e-05	3.83e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTEN—malignant glioma	1.53e-05	3.81e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.47e-05	3.64e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.45e-05	3.61e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS2—malignant glioma	1.45e-05	3.61e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS2—malignant glioma	1.44e-05	3.58e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—AKT1—malignant glioma	1.43e-05	3.56e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—AKT1—malignant glioma	1.42e-05	3.53e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTEN—malignant glioma	1.38e-05	3.42e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CAV1—malignant glioma	1.37e-05	3.41e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTEN—malignant glioma	1.34e-05	3.34e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—AKT1—malignant glioma	1.32e-05	3.28e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTEN—malignant glioma	1.27e-05	3.15e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.26e-05	3.12e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTEN—malignant glioma	1.26e-05	3.12e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.25e-05	3.11e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PPARG—malignant glioma	1.21e-05	3e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.1e-05	2.73e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.09e-05	2.7e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PIK3CA—malignant glioma	1.08e-05	2.69e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—AKT1—malignant glioma	1.03e-05	2.55e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PIK3CA—malignant glioma	9.72e-06	2.41e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.59e-06	2.38e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS2—malignant glioma	9.5e-06	2.36e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PIK3CA—malignant glioma	9.49e-06	2.35e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PIK3CA—malignant glioma	8.94e-06	2.22e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—AKT1—malignant glioma	8.9e-06	2.21e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PIK3CA—malignant glioma	8.86e-06	2.2e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—AKT1—malignant glioma	8.84e-06	2.2e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTEN—malignant glioma	8.28e-06	2.06e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—AKT1—malignant glioma	7.94e-06	1.97e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—AKT1—malignant glioma	7.75e-06	1.92e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—AKT1—malignant glioma	7.3e-06	1.81e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—AKT1—malignant glioma	7.24e-06	1.8e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.84e-06	1.45e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—AKT1—malignant glioma	4.77e-06	1.19e-05	CbGpPWpGaD
